BENEFIT-C: Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Study Details
Study Description
Brief Summary
The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:
-
Do patient financial incentives for completing colorectal cancer screening increase screening completion?
-
Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?
Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.
Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Full financial incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening |
Behavioral: Financial incentive for colorectal cancer screening
$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment
Behavioral: Financial incentive for flu shot
$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
Behavioral: Financial incentive for COVID-19 shot
$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment
|
| Active Comparator: Partial financial incentives $50/service patient financial incentive for completion of: COVID-19 shot, flu shot |
Behavioral: Financial incentive for flu shot
$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
Behavioral: Financial incentive for COVID-19 shot
$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment
|
Outcome Measures
Primary Outcome Measures
- Difference in proportion of participants completing colorectal cancer screening between study arms [Two months]
Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment
Secondary Outcome Measures
- Difference in proportion of participants completing COVID-19 shot between study arms [Two months]
Completion of COVID-19 shot as documented in electronic health record within two months of study enrollment
- Difference in proportion of participants completing flu shot between study arms [Two months]
Completion of flu shot as documented in electronic health record within two months of study enrollment
- Difference in proportion of participants completing at least one of the following services between study arms: colorectal cancer screening, COVID-19 shot, flu shot [Two months]
Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, *OR* flu shot as documented in electronic health record within two months of study enrollment
- Difference in proportion of participants completing all three services between study arms: colorectal cancer screening, COVID-19 shot, flu shot [Two months]
Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, *AND* flu shot as documented in electronic health record within two months of study enrollment
Other Outcome Measures
- Number of patients approached for recruitment [Three months]
Number of patients with reachable phone numbers
- Number of patients assessed for eligibility [Three months]
Number of patients who begin eligibility screener
- Number of patients randomized [Three months]
Number of patients who consent and are randomized
- Number of patients who receive intended treatment [Three months]
Number of patients who complete outreach call
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 45 to 75
-
Receive care at participating primary care clinic
-
Due for colorectal cancer screening
-
Ability to understand and speak English
Exclusion Criteria:
-
Currently participating in another clinical trial or research study on colorectal cancer screening
-
Unable or unwilling to give informed consent
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Tulane University School of Medicine | New Orleans | Louisiana | United States | 70112 |
Sponsors and Collaborators
- Tulane University
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Marie A Krousel-Wood, MD, MSPH, Tulane University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2020-1600-BENC
- OT2HL158287